Kennedy Capital Management’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $91.7K | Buy |
12,174
+531
| +5% | +$4K | ﹤0.01% | 580 |
|
|
2025
Q1 | $88.1K | Sell |
11,643
-99,406
| -90% | -$753K | ﹤0.01% | 641 |
|
|
2024
Q4 | $1.35M | Buy |
+111,049
| New | +$1.35M | 0.03% | 564 |
|
|
2024
Q2 | – | Sell |
-84,234
| Closed | -$1.44M | – | 708 |
|
|
2024
Q1 | $1.44M | Sell |
84,234
-75,778
| -47% | -$1.29M | 0.03% | 579 |
|
|
2023
Q4 | $1.63M | Sell |
160,012
-329,434
| -67% | -$3.36M | 0.04% | 528 |
|
|
2023
Q3 | $4.43M | Sell |
489,446
-52,476
| -10% | -$475K | 0.11% | 310 |
|
|
2023
Q2 | $5.83M | Sell |
541,922
-43,020
| -7% | -$463K | 0.14% | 265 |
|
|
2023
Q1 | $5.98M | Sell |
584,942
-28,647
| -5% | -$293K | 0.18% | 217 |
|
|
2022
Q4 | $6.47M | Sell |
613,589
-25,321
| -4% | -$267K | 0.18% | 194 |
|
|
2022
Q3 | $8.19M | Buy |
638,910
+604,563
| +1,760% | +$7.75M | 0.24% | 134 |
|
|
2022
Q2 | $440K | Buy |
+34,347
| New | +$440K | 0.01% | 552 |
|